Ixico (LON:IXI) announced its quarterly earnings results on Tuesday. The company reported GBX (2) (($0.03)) earnings per share for the quarter, missing analysts’ consensus estimates of GBX (1.50) (($0.02)) by GBX (0.50) (($0.01)), Bloomberg Earnings reports.
Shares of LON IXI traded down GBX 1.50 ($0.02) during midday trading on Thursday, reaching GBX 21.50 ($0.28). 44,183 shares of the stock were exchanged, compared to its average volume of 2,474. Ixico has a 12 month low of GBX 22.20 ($0.29) and a 12 month high of GBX 39.99 ($0.52).
Ixico Company Profile
IXICO plc provides technology enabled services to the biopharmaceutical industry worldwide. The company's technologies include Assessa, a secure online digital platform that provides clinical decision support for patient selection and post-marketing surveillance; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, QC, and reading/analysis to reporting and data transfer.
Featured Story: Technical Analysis of Stocks, How Can It Help
Receive News & Ratings for Ixico Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ixico and related companies with MarketBeat.com's FREE daily email newsletter.